Cytoreductive surgery plus chemotherapy versus chemotherapy alone for recurrent epithelial ovarian cancer
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Cytoreductive Surgery Plus Chemotherapy Versus Chemotherapy Alone for Recurrent Epithelial Ovarian Cancer." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/439507/all/Cytoreductive_surgery_plus_chemotherapy_versus_chemotherapy_alone_for_recurrent_epithelial_ovarian_cancer. Accessed 12 October 2024.
Cytoreductive surgery plus chemotherapy versus chemotherapy alone for recurrent epithelial ovarian cancer. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439507/all/Cytoreductive_surgery_plus_chemotherapy_versus_chemotherapy_alone_for_recurrent_epithelial_ovarian_cancer. Accessed October 12, 2024.
Cytoreductive surgery plus chemotherapy versus chemotherapy alone for recurrent epithelial ovarian cancer. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/439507/all/Cytoreductive_surgery_plus_chemotherapy_versus_chemotherapy_alone_for_recurrent_epithelial_ovarian_cancer
Cytoreductive Surgery Plus Chemotherapy Versus Chemotherapy Alone for Recurrent Epithelial Ovarian Cancer [Internet]. In: Cochrane Abstracts. [cited 2024 October 12]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/439507/all/Cytoreductive_surgery_plus_chemotherapy_versus_chemotherapy_alone_for_recurrent_epithelial_ovarian_cancer.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Cytoreductive surgery plus chemotherapy versus chemotherapy alone for recurrent epithelial ovarian cancer
ID - 439507
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/439507/all/Cytoreductive_surgery_plus_chemotherapy_versus_chemotherapy_alone_for_recurrent_epithelial_ovarian_cancer
DB - Evidence Central
DP - Unbound Medicine
ER -